NEWS & UPDATES
While medicines and vaccines are studied in well controlled clinical trials and reviewed by regulatory authorities with the aim of ensuring benefits outweigh risks, some adverse effects are observed only once the product is authorized by regulators and used by a larger population in real world conditions. It is therefore essential that medical products continue to be monitored for their effectiveness and safety post release.

MEDICAL PRODUCT ALERT NO. 3/2025: FALSIFIED IMFINZI (DURVALUMAB) INJECTION 500MG/10ML IDENTIFIED IN THE WHO EASTERN MEDITERRANEAN AND EUROPEAN REGIONS
Medical Product Quality Alert_Durvalumab (002)Download

PRODUCT ALERT : WITHDRAW OF ANACONDA SEX BOOSTER COFFEE
Public Notice Withdraw of Anaconda Sex Booster CoffeeDownload